Azenta (AZTA) Cash from Investing Activities (2010 - 2026)
Azenta (AZTA) recorded quarterly Cash from Investing Activities of -$78.0 million in Q1 2026, down 312.06% quarter-over-quarter from $36.8 million in Q4 2025, and up 43.77% on a YoY basis from -$54.2 million in Q1 2025.
Azenta (AZTA) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Azenta's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$78.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 43.77% year-over-year to -$78.0 million; the TTM figure through Mar 2026 stood at -$209.6 million (down 162.34% YoY), while the FY2025 annual figure was -$90.5 million, down 140.25% from the prior year.
- Cash from Investing Activities was -$78.0 million for Q1 2026 at Azenta, down from $36.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.8 billion in Q1 2022 to a low of -$374.5 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged $125.5 million across 5 years, with a median of $57.3 million in 2022.
- Biggest YoY gain for Cash from Investing Activities was 62692.23% in 2022; the steepest drop was 2038.04% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at $56.4 million in 2022, then soared by 75.71% to $99.0 million in 2023, then slipped by 22.16% to $77.1 million in 2024, then tumbled by 52.3% to $36.8 million in 2025, then slumped by 312.06% to -$78.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$78.0 million (Q1 2026), $36.8 million (Q4 2025), and -$29.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | -77.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.98 Mn |
| Mar 31, 2026 | -77.98 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Jun 30, 2025 | -29.70 Mn |
| Jun 30, 2025 | -29.70 Mn |
| Mar 31, 2025 | -138.67 Mn |
| Mar 31, 2025 | -138.67 Mn |
| Dec 31, 2024 | 77.09 Mn |
| Dec 31, 2024 | 77.09 Mn |
| Sep 30, 2024 | 198.01 Mn |
| Sep 30, 2024 | 198.01 Mn |
| Jun 30, 2024 | 199.74 Mn |
| Jun 30, 2024 | 199.74 Mn |
| Mar 31, 2024 | -272.03 Mn |
| Mar 31, 2024 | -272.03 Mn |
| Dec 31, 2023 | 99.03 Mn |
| Dec 31, 2023 | 99.03 Mn |
| Sep 30, 2023 | 102.49 Mn |
| Sep 30, 2023 | 102.49 Mn |